RxDoctor Payments Data

Thuong Trinh, DO

Otolaryngology/Facial Plastic Surgery · Saint Cloud, FLNPI 1831308907

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,471 of the $3,961 with a category attached, or 62.4%. Intersect ENT, Inc. accounts for 71.4% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $2,776 and has fallen 97.2% since, to $79 in 2025.

$3,961in general payments, 2019–2025

Across 44 payments — averaging $90.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$3K
  • Acclarent, Inc$351
  • Integra Lifesciences Corporation$239
  • GSK$96
  • Aerin Medical Inc.$69
  • Johnson & Johnson$67
  • plus $309 from 12 others

What the payments were for

  • Consulting fees$1003%
  • Travel & lodging$2,47162%
  • Food & beverage$1,39035%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,961 in reported general payments places this provider in the 70th percentile of 48 otolaryngology/facial plastic surgery providers in Florida.

See all otolaryngology/facial plastic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$57,133
Medicare patients
319
Services billed
533

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl173$3,988
Fluticasone Propionate129$1,855
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth16$1,657
Tobramycin-DexamethasoneTobramycin/Dexamethasone20$1,655
Ofloxacin38$1,513
Cefdinir65$1,223
Azelastine-FluticasoneAzelastine/Fluticasone14$1,190
Fluocinolone Acetonide Oil28$917
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$833
Famotidine43$816
Ipratropium Bromide21$601
Mometasone Furoate14$499
Montelukast Sodium38$493
Mupirocin57$390
Levocetirizine Dihydrochloride14$290

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Saint Cloud

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →